Приказ основних података о документу

dc.creatorGeronikaki, Athina
dc.creatorKartsev, Victor
dc.creatorEleftheriou, Phaedra
dc.creatorPetrou, Anthi
dc.creatorGlamočlija, Jasmina
dc.creatorĆirić, Ana
dc.creatorSoković, Marina
dc.date.accessioned2020-11-19T10:27:08Z
dc.date.available2020-11-19T10:27:08Z
dc.date.issued2020
dc.identifier.issn1568-0266
dc.identifier.urihttps://www.eurekaselect.com/186178/article
dc.identifier.urihttps://radar.ibiss.bg.ac.rs/handle/123456789/4000
dc.description.abstractBackground: Although a great number of the targets of antimicrobial therapy have been achieved, it remains among the first fields of pharmaceutical research, mainly because of the development of resistant strains. Docking analysis may be an important tool in the research for the development of more effective agents against specific drug targets or multi-target agents 1-3. Methods: In the present study, based on docking analysis, ten tetrahydrothiazolo[2,3-a]isoindole derivatives were chosen for the evaluation of the antimicrobial activity. Results: All compounds showed antibacterial activity against eight Gram-positive and Gram-negative bacterial species being, in some cases, more potent than ampicillin and streptomycin against all species. The most sensitive bacteria appeared to be S. aureus and En. Cloacae, while M. flavus, E. coli and P. aeruginosa were the most resistant ones. The compounds were also tested for their antifungal activity against eight fungal species. All compounds exhibited good antifungal activity better than reference drugs bifonazole (1.4 – 41 folds) and ketoconazole (1.1 – 406 folds) against all fungal species. In order to elucidate the mechanism of action, docking studies on different antimicrobial targets were performed. Conclusion: According to docking analysis, the antifungal activity can be explained by the inhibition of the CYP51 enzyme for most compounds with a better correlation of the results obtained for the P.v.c. strain (linear regression between estimated binding Energy and log(1/MIC) with R 2 =0.867 and p=0.000091 or R 2 = 0.924, p= 0.000036, when compound 3 is excluded.en
dc.publisherBentham Science Publishers Ltd.
dc.rightsrestrictedAccess
dc.sourceCurrent Topics in Medicinal Chemistry
dc.subjectAntimicrobial Activity
dc.subjectMolecular docking studies
dc.subjectStrains
dc.subjectDrug
dc.subjectAntifungul activity
dc.subjectE. coli
dc.titleSubstituted 6,7-dimethoxy-5-oxo-2,3,5,9b-tetrahydrothiazolo[2,3-a]isoindole-3-1,1-dioxidederivatives with antimicrobial activity and docking assisted prediction of the mechanism of their antibacterial and antifungal propertiesen
dc.typearticleen
dc.rights.licenseARR
dcterms.abstractГероникаки, Aтхина; Елефтхериоу, Пхаедра; Картсев, Вицтор; Соковић, Марина; Ћирић, Aна; Гламочлија, Јасмина; Петроу, Aнтхи;
dc.rights.holder© 2020 Bentham Science Publishers.
dc.citation.issue29
dc.citation.volume20
dc.identifier.doi10.2174/1568026620666200922114735
dc.identifier.pmid32962619
dc.identifier.scopus2-s2.0-85095778743
dc.identifier.wos000592667300004
dc.citation.apaGeronikaki, A., Kartsev, V., Eleftheriou, P., Petrou, A., Glamočlija, J., Ciric, A., et al. (2020). Substituted 6,7-dimethoxy-5-oxo-2,3,5,9b-tetrahydrothiazolo[2,3-a]isoindole-3-1,1-dioxidederivatives with antimicrobial activity and docking assisted prediction of the mechanism of their antibacterial and antifungal properties. Current Topics in Medicinal Chemistry, 20(29), 2681–2691.
dc.citation.vancouverGeronikaki A, Kartsev V, Eleftheriou P, Petrou A, Glamočlija J, Ciric A, Soković M. Substituted 6,7-dimethoxy-5-oxo-2,3,5,9b-tetrahydrothiazolo[2,3-a]isoindole-3-1,1-dioxidederivatives with antimicrobial activity and docking assisted prediction of the mechanism of their antibacterial and antifungal properties. Curr Top Med Chem. 2020;20(29):2681–91.
dc.citation.spage2681
dc.citation.epage2691
dc.type.versionpublishedVersion
dc.citation.rankM22


Документи

ДатотекеВеличинаФорматПреглед

Уз овај запис нема датотека.

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу